Indication: Tukysa, a kinase inhibitor

Tuksya is a kinase inhibitor recommended in combination with Trastuzumab and Capecitabine for treating adult patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases who received one or more prior anti-HER2-based regimens in the metastatic setting and in combination with Trastuzumab for the treatment of adult patients with RAS wild-type HER2-positive […]

Metastatic Breast Cancer Treatment Options available

What is Metastatic Breast Cancer? When healthy cells change and grow out of control, creating a mass or sheet of cells called a tumor, this process is known as Cancer. A cancerous tumor is malignant, referring to the fact that it can grow and out spread to other parts of the body. When Breast cancer […]